3rd Peptide-Based Therapeutics Summit 2026
Peptide therapies are rapidly becoming a disruptive modality, with Unnatural Products scoring a $1.7B deal with Novartis , Vivtex 's $2.1B partnership with Novo Nordisk , and Pinnacle Medicines raising $89M fo…
Read guide →